15:53 , Mar 28, 2017 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Stroke In vitro and mouse studies identified a spider venom-derived peptide inhibitor of ASIC1A that could help treat stroke. In in vitro activity assays, a peptide (Hi1a) from the venom of the Hadronyche infensa...
08:00 , Dec 24, 2012 |  BioCentury  |  Emerging Company Profile

Aros: Easing IBS pain

Aros Pharma ApS has found a new way to treat pain associated with irritable bowel syndrome. The company is developing an ASIC1A antagonist that specifically reduces gastrointestinal pain and could be an effective adjunct therapy...
07:00 , May 14, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression Amiloride-sensitive cation channel 2, neuronal (ACCN2; ASIC1) Mouse studies suggest that inhibiting ASIC1a could help treat depression. In mice, Asic1a...